|
| 36659903 | Development and Validation of Coding Algorithms to Identify Patients with Incident Non-Small Cell Lung Cancer in United States Healthcare Claims Data. | Clin Epidemiol | 2023 |
| 37067668 | Gaps Remain for Achieving HbA1c Targets for People with Type 1 or Type 2 Diabetes Using Insulin: Results from NHANES 2009-2020. | Diabetes Ther | 2023 |
| 36799018 | Trajectory of glycated haemoglobin over time, using real-world data, in type 2 diabetes patients with obesity on a U-100 basal-bolus insulin regimen. | Diabetes Obes Metab | 2023 |
| 35213669 | Breast cancer-specific mortality in early breast cancer as defined by high-risk clinical and pathologic characteristics. | PLoS One | 2022 |
| 35866412 | Development of a claims-based flare algorithm for systemic lupus erythematosus. | Curr Med Res Opin | 2022 |
| 30141730 | Trends in Depressed Mood and Suicidal Behaviors Among Female High School Students Who Engaged in Physical Fighting. | J Interpers Violence | 2021 |
| 33868458 | Validation of claims-based indicators used to identify flare-ups in inflammatory bowel disease. | Therap Adv Gastroenterol | 2021 |
| 34212316 | Differential Cost-Sharing Undermines Treatment Adherence to Combination Therapy: Evidence from Diabetes Treatment. | Diabetes Ther | 2021 |
| 33012044 | Development and validation of coding algorithms to identify patients with incident lung cancer in United States healthcare claims data. | Pharmacoepidemiol Drug Saf | 2020 |
| 31168561 | Is Interferon Therapy for Hepatitis C Infection a Treatable Risk Factor for Parkinson Disease? | JAMA Neurol | 2019 |
| 30977712 | Treatment patterns and predictors of costs among patients with migraine: evidence from the United States medical expenditure panel survey. | J Med Econ | 2019 |
| 29065729 | Factors associated with stroke, myocardial infarction, ischemic heart disease, unstable angina, or mortality in patients from real world clinical practice with newly-diagnosed type 2 diabetes and early glycemic control. | Curr Med Res Opin | 2018 |
| 26689451 | Obesity and glycemic control in patients with diabetes mellitus: Analysis of physician electronic health records in the US from 2009-2011. | J Diabetes Complications | 2016 |
| 26671598 | Frequency of skeletal-related events and associated healthcare resource use and costs in US patients with multiple myeloma. | J Med Econ | 2016 |
| 27532927 | Cost of Antihyperglycemic Medications in the United States. | JAMA | 2016 |
| 28848840 | Clinical Trial Design for Alpha-1 Antitrypsin Deficiency: A Model for Rare Diseases. | Chronic Obstr Pulm Dis | 2015 |
| 23489710 | Expectations about insulin therapy, perceived insulin-delivery system social acceptability, and insulin treatment satisfaction contribute to decreases in insulin therapy self-efficacy in patients with type 2 diabetes after 36 weeks insulin therapy. | J Diabetes | 2013 |
| 23884467 | An integrated clinico-metabolomic model improves prediction of death in sepsis. | Sci Transl Med | 2013 |
| 21504333 | Ability to perform daily physical activities in individuals with type 2 diabetes and moderate obesity: a preliminary validation of the Impact of Weight on Activities of Daily Living Questionnaire. | Diabetes Technol Ther | 2011 |
| 21317650 | Is worsening multiple organ failure the cause of death in patients with severe sepsis? | Crit Care Med | 2011 |
| 20171298 | Magnitude and regional distribution of cartilage loss associated with grades of joint space narrowing in radiographic osteoarthritis--data from the Osteoarthritis Initiative (OAI). | Osteoarthritis Cartilage | 2010 |
| 20589703 | One-year change in radiographic joint space width in patients with unilateral joint space narrowing: data from the Osteoarthritis Initiative. | Arthritis Care Res (Hoboken) | 2010 |
| 19242329 | Predisposition, insult/infection, response, and organ dysfunction: A new model for staging severe sepsis. | Crit Care Med | 2009 |
| 19714595 | Magnetic resonance imaging-based cartilage loss in painful contralateral knees with and without radiographic joint space narrowing: Data from the Osteoarthritis Initiative. | Arthritis Rheum | 2009 |
| 18386762 | A registry of patients treated with drotrecogin alfa (activated) in Belgian intensive care units--an observational study. | Acta Clin Belg | 2008 |
| 18786266 | Influence of enrollment sequence effect on observed outcomes in the ADDRESS and PROWESS studies of drotrecogin alfa (activated) in patients with severe sepsis. | Crit Care | 2008 |
| 18394162 | Protein C: a potential biomarker in severe sepsis and a possible tool for monitoring treatment with drotrecogin alfa (activated). | Crit Care | 2008 |
| 17723900 | Analysis of efficacy and safety of drotrecogin alfa (activated) in surgical patients, using an international integrated database. | Surgery | 2007 |
| 18269691 | The protein C pathway: implications for the design of the RESPOND study. | Crit Care | 2007 |
| 17548026 | International integrated database for the evaluation of severe sepsis and drotrecogin alfa (activated) therapy: 28-day survival and safety. | J Crit Care | 2007 |
| 17699383 | Elevated plasma concentrations of IL-6 and elevated APACHE II score predict acute kidney injury in patients with severe sepsis. | Clin J Am Soc Nephrol | 2007 |
| 16780598 | Protein C concentrations in severe sepsis: an early directional change in plasma levels predicts outcome. | Crit Care | 2006 |
| 17094791 | Drotrecogin alfa (activated): current evidence supports treatment for severe sepsis patients with a high risk of death. | Crit Care | 2006 |
| 16709322 | International INtegrated Database for the Evaluation of severe sePsis and drotrecogin alfa (activated) THerapy: component trials and statistical methods for INDEPTH. | Curr Med Res Opin | 2006 |
| 15699837 | Dynamic evolution of coagulopathy in the first day of severe sepsis: relationship with mortality and organ failure. | Crit Care Med | 2005 |
| 16237651 | Underlying disorders and their impact on the host response to infection. | Clin Infect Dis | 2005 |
| 16280057 | Lack of evidence for qualitative treatment by disease severity interactions in clinical studies of severe sepsis. | Crit Care | 2005 |
| 15118522 | Severe protein C deficiency predicts early death in severe sepsis. | Crit Care Med | 2004 |
| 15640632 | Hospital mortality and resource use in subgroups of the Recombinant Human Activated Protein C Worldwide Evaluation in Severe Sepsis (PROWESS) trial. | Crit Care Med | 2004 |
| 15599140 | Sources of variability on the estimate of treatment effect in the PROWESS trial: implications for the design and conduct of future studies in severe sepsis. | Crit Care Med | 2004 |
| 14770034 | Effects of drotrecogin alfa (activated) in human endotoxemia. | Shock | 2004 |
| 15118531 | Leukocyte and endothelial cell interactions in sepsis: relevance of the protein C pathway. | Crit Care Med | 2004 |
| 15118525 | Effect of factor V Leiden polymorphism in severe sepsis and on treatment with recombinant human activated protein C. | Crit Care Med | 2004 |
| 12830408 | Systemic host responses in severe sepsis analyzed by causative microorganism and treatment effects of drotrecogin alfa (activated). | Clin Infect Dis | 2003 |
| 12633688 | Non-immunologic vascular failure of the transplanted heart. | J Heart Lung Transplant | 2003 |
| 12433514 | C-reactive protein, arterial endothelial activation, and development of transplant coronary artery disease: a prospective study. | Lancet | 2002 |
| 11133233 | Increased vascular endothelial growth factor expression in human hearts with microvascular fibrin. | J Mol Cell Cardiol | 2001 |
| 11224642 | Pathologic markers of allograft arteriopathy: insight into the pathophysiology of cardiac allograft chronic rejection. | Curr Opin Cardiol | 2001 |
| 12102259 | Immunohistochemical model to predict risk for coronary artery disease and failure in heart transplant patients. | Am J Transplant | 2001 |
| 11468609 | Work interrupted: a comparison of workplace interruptions in emergency departments and primary care offices. | Ann Emerg Med | 2001 |